V. A. M. HASHIMOTO, E. V. DE PAULA, M. P. COLELLA, M. M. LUZ FIUSA, S. A. L. MONTALVAO, T. F. G. S. MACHADO, F. A. ORSI, J. M. ANNICHINO-BIZZACCHI
Vitamin K antagonists (VKAs), mainly represented by warfarin, remain one of the most often used class of drugs. However, due to the peculiar pharmacokinetic
and pharmacodynamic profile of these agents, laboratory monitoring of the prothrombin time…
